Prognostic and predictive value of circulating ESR1 mutations in metastatic breast cancer patients (mBC) progressing under aromatase inhibitor (AI) treatment.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 511-511 ◽  
Author(s):  
Laetitia Augusto ◽  
Nasrin Sarafan-Vasseur ◽  
Anne Perdrix ◽  
Ludivine Beaussire ◽  
Julien Delacour ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Predictive Value ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Esr1 Mutations

scholarly journals Efficacy of Exemestane After Nonsteroidal Aromatase inhibitor Use in Metastatic Breast Cancer Patients

2012 ◽  
Vol 13 (3) ◽  
pp. 979-983 ◽  
Author(s):  
Sun-Hye Kim ◽  
In-Hae Park ◽  
Hye-Won Lee ◽  
Keun-Seok Lee ◽  
Byung-Ho Nam ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Breast Cancer Patients

scholarly journals Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients

2017 ◽  
Vol 10 (5) ◽  
pp. 766-771 ◽  
Author(s):  
Takashi Takeshita ◽  
Yutaka Yamamoto ◽  
Mutsuko Yamamoto-Ibusuki ◽  
Mai Tomiguchi ◽  
Aiko Sueta ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Tumor Tissue ◽  
Metastatic Breast ◽  
Plasma Samples ◽  
Breast Cancer Patients ◽  
Esr1 Mutations
Sign in / Sign up

Export Citation Format

Share Document